Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Episode 26 December 07, 2022 00:39:02
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.
Few & Far Between: How Biotech Gets Built
Episode 26: Chris Min, CMO and Interim CEO at Longeveron, Inc.

Dec 07 2022 | 00:39:02

/

Show Notes

"Try to find the people who have a really strong background in regulatory science, who really understand the fundamentals, and who you believe can think creatively about the challenges of the cell therapy space." - Chris Min, Longeveron

Biorasi welcomes Chris Min to the Few & Far Between podcast for an inside look at the cell therapy industry and the importance of finding the right team to support your clinical trials. 

Other Episodes

Episode 48

February 18, 2025 00:38:46
Episode Cover

Episode 48: John Celebi, President and CEO, Sensei Bio

"You have to have the right people, the right team, and good science." - John Celebi, President and CEO, Sensei Bio Welcome back to...

Listen

Episode 63

October 28, 2025 01:01:16
Episode Cover

Video Episode 63 - Bruce Leuchter, MD, President and CEO of Neurvati Neurosciences

What if the future of biotech is actually late-stage execution? Welcome to our first video episode of the Biorasi Few & Far Between podcast...

Listen

Episode 20

May 18, 2022 00:30:43
Episode Cover

Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E....

Listen